Tags: SCLC
Immunotherapy for Small Cell Lung Cancer: Established Applications and Novel Approaches
Abstract: Small cell lung cancer (SCLC) is a devastating disease that has a case fatality rate of more than 90% despite best available treatments. As a […]
Hem/Onc News
Pembrolizumab Receives Regular Approval in Metastatic Nonsquamous NSCLC On August 20, the US Food and Drug Administration (FDA) granted regular approval to pembrolizumab (Keytruda, Merck) for […]
Looking Ahead to New Therapies in Small Cell Lung Cancer
H&O How common is small cell lung cancer (SCLC)? CR Approximately 25,000 to 30,000 cases of SCLC occur each year in the United States, a number […]